日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor Homing Nanoparticle Immunotherapy for Acute Clearance and Mitigation of T-cell Exhaustion in Humanized High-Risk Neuroblastoma

肿瘤靶向纳米颗粒免疫疗法用于人源化高危神经母细胞瘤的急性清除和T细胞耗竭缓解

Kane, Griffin I; Diaz-Infante, Miranda B; Wigglesworth, Kim; Lusi, Ellis; Brassil, Meghan; Rozen, Esteban J; Kady, Jamie; Mori, Haruka; Lukas, John; Naylor, Tiana; Dinnell, Ronnie W; Murphy, Katherine C; Alarcon, Christian Bernard B; Ruscetti, Marcus; Brehm, Michael; Shohet, Jason M; Atukorale, Prabhani U

MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T Cell and Immunotherapy Responses in Prostate Cancer.

MYC 和 p53 的改变通过 VEGF 信号传导协同作用,抑制前列腺癌中的细胞毒性 T 细胞和免疫疗法反应

Murphy Katherine C, DeMarco Kelly D, Zhou Lin, Peura Jessica, Giwa Hadiya K, Lopez-Diaz Yvette, Ho Yu-Jui, Li Junhui, Bai Shi, Simin Karl, Zhu Lihua J, Pitarresi Jason R, Mercurio Arthur M, Ruscetti Marcus

PPT1 is a negative regulator of STING signaling in cancer cells and its inhibition reactivates immune surveillance in cold tumors

PPT1是癌细胞中STING信号的负调控因子,抑制PPT1可以重新激活冷肿瘤中的免疫监视功能。

Chowdhury, Shreya R; Parikh, Chaitanya N; Kaur, Arshia N; DeMarco, Kelly D; Giwa, Hadiya K; Mishra, Alok K; Murphy, Katherine C; Zhou, Lin; Ma, Boyang; Ye, Tianyi; Li, Junhui; Liu, Haibo; Bai, Shi; Johnson, Calvin; Simin, Karl; Pitarresi, Jason R; Zhu, Lihua Julie; Watson, Emma V; Kelliher, Michelle A; Green, Michael R; Fitzgerald, Katherine A; Ruscetti, Marcus

Advances in Making Cancer Mouse Models More Accessible and Informative through Non-Germline Genetic Engineering

通过非生殖系基因工程技术,使癌症小鼠模型更易于获取和提供更多信息。

Murphy, Katherine C; Ruscetti, Marcus

Dietary Fatty Acid Modification for the Treatment of Aspirin-Exacerbated Respiratory Disease: A Prospective Pilot Trial

膳食脂肪酸调整治疗阿司匹林加重呼吸系统疾病:一项前瞻性试点试验

Schneider, Thomas R; Johns, Christina B; Palumbo, Marina L; Murphy, Katherine C; Cahill, Katherine N; Laidlaw, Tanya M